Ceylon Cardamom (Elettaria cardamomum)

Ceylon cardamom (Elettaria cardamomum) contains bioactive compounds like cineole and α-terpineol that provide anti-inflammatory and cardiovascular benefits. Clinical studies demonstrate significant reductions in inflammatory markers and blood pressure improvements with regular supplementation.

Category: Seed Evidence: 2/10 Tier: Moderate (some RCTs)
Ceylon Cardamom (Elettaria cardamomum) — Hermetica Encyclopedia

Origin & History

Ceylon cardamom (Elettaria cardamomum) refers to the aromatic seeds from a perennial herbaceous plant in the Zingiberaceae family, native to the Western Ghats of India, Sri Lanka, and Southeast Asia. The green pods containing the seeds are harvested, dried, and used whole, powdered, or as extracts, with the seeds containing 3-6% essential oil rich in volatile compounds.

Historical & Cultural Context

Elettaria cardamomum has been used for over 2,000 years in Ayurvedic and Unani medicine systems throughout India, Sri Lanka, and the Middle East. Traditional applications include digestive issues, respiratory ailments, diabetes, hyperlipidemia, obesity, and hypertension, with seeds consumed as powder, decoction, or culinary spice.

Health Benefits

• Significantly reduces inflammation markers (hs-CRP by -0.78 mg/L, IL-6) based on meta-analysis of RCTs, with stronger effects in trials ≥10 weeks
• Improves blood pressure and cardiovascular health markers according to systematic review evidence
• Supports metabolic syndrome management including diabetes, hyperlipidemia, and obesity per multiple RCT reviews
• May enhance glycemic control and insulin sensitivity in type 2 diabetes (pending RCT results)
• Demonstrates antioxidant effects potentially through SIRT1/irisin modulation pathways (preliminary evidence)

How It Works

Ceylon cardamom's primary bioactive compounds cineole and α-terpineol inhibit nuclear factor-κB (NF-κB) signaling pathways, reducing pro-inflammatory cytokine production including IL-6 and TNF-α. The compounds also activate endothelial nitric oxide synthase (eNOS), promoting vasodilation and improving blood flow. Additionally, cardamom's volatile oils modulate cyclooxygenase-2 (COX-2) activity, contributing to its anti-inflammatory effects.

Scientific Research

A meta-analysis of RCTs found cardamom significantly reduced inflammation markers (hs-CRP, IL-6) and improved blood pressure, particularly in trials lasting ≥10 weeks. A systematic review confirmed effects on metabolic syndrome components across multiple RCTs, while a registered protocol (PMID not provided) is evaluating cardamom's effects on HbA1c, lipids, and oxidative stress markers in T2DM patients.

Clinical Summary

Meta-analyses of randomized controlled trials show Ceylon cardamom significantly reduces high-sensitivity C-reactive protein (hs-CRP) by 0.78 mg/L and interleukin-6 levels. Systematic reviews demonstrate consistent blood pressure reductions and cardiovascular health improvements across multiple studies. Trials lasting 10 weeks or longer show stronger anti-inflammatory effects compared to shorter durations. Current evidence comes primarily from small to moderate-sized RCTs, with larger long-term studies needed to confirm optimal dosing protocols.

Nutritional Profile

Per 100g dried Ceylon cardamom seeds: Calories ~311 kcal, Carbohydrates ~68g (of which dietary fiber ~28g, sugars ~0.7g), Protein ~10.8g, Fat ~6.7g (of which saturated ~0.68g, monounsaturated ~0.87g, polyunsaturated ~0.43g). Key minerals: Manganese ~28mg (1400% DV - exceptionally high, critical for antioxidant enzyme superoxide dismutase), Iron ~13.97mg (~78% DV), Magnesium ~229mg (~57% DV), Calcium ~383mg (~38% DV), Potassium ~1119mg (~32% DV), Phosphorus ~178mg (~25% DV), Zinc ~7.47mg (~68% DV), Copper ~0.383mg (~43% DV). Vitamins: Vitamin C ~21mg (~23% DV), Niacin (B3) ~1.102mg, Riboflavin (B2) ~0.182mg, Thiamine (B1) ~0.198mg, Pyridoxine (B6) ~0.23mg, Folate ~2mcg. Primary bioactive compounds: Volatile essential oil content 2-8% of seed weight, dominated by 1,8-cineole (eucalyptol) at 20-60% of oil fraction, α-terpinyl acetate at 30-53% of oil fraction (the most characteristic compound of true Ceylon cardamom), linalool ~3%, linalool acetate ~3%, sabinene ~3%, myrcene ~2%, α-pinene ~1.5%, β-pinene ~1%, limonene ~2%. Non-volatile phenolic compounds include flavonoids (quercetin, kaempferol glycosides), phenolic acids (caffeic acid, protocatechuic acid, vanillic acid), and condensed tannins at ~1.5-2% dry weight. Fixed oils contain linoleic acid and oleic acid as predominant fatty acids. Bioavailability notes: Essential oil compounds are highly bioavailable via inhalation and gastrointestinal absorption; 1,8-cineole reaches systemic circulation rapidly (~30 min post-ingestion). Mineral bioavailability is moderately limited by presence of phytates and oxalates (~15-25% inhibition of iron and zinc absorption); grinding or soaking improves mineral absorption. Phenolic bioavailability is enhanced by the food matrix's fiber content through colonic fermentation yielding short-chain fatty acids. Ceylon cardamom (Elettaria cardamomum) is distinguished from Amomum species by its higher α-terpinyl acetate to 1,8-cineole ratio, conferring a sweeter, more delicate aroma profile. Typical culinary serving of 2g ground cardamom provides ~6mg manganese (~300% DV), meaningful contribution to daily mineral needs despite small quantity used.

Preparation & Dosage

Clinically studied doses range from 3 g/day of cardamom powder (combined with other spices) to unspecified amounts in inflammation and metabolic trials. No standardized extract dosing established in current research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cinnamon, Turmeric, Ginger, Alpha-lipoic acid, Chromium

Safety & Interactions

Ceylon cardamom is generally well-tolerated at culinary doses with minimal reported side effects. High doses may cause gastrointestinal upset, including nausea or stomach irritation in sensitive individuals. Cardamom may potentiate blood pressure medications due to its hypotensive effects, requiring monitoring in patients on antihypertensive drugs. Pregnancy and breastfeeding safety data is limited, though culinary amounts are considered safe while therapeutic doses should be avoided.